IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SIGALA, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.215
EU - Europa 3.849
AS - Asia 2.307
SA - Sud America 16
AF - Africa 15
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.170
CN - Cina 1.083
UA - Ucraina 860
IT - Italia 622
PL - Polonia 556
SG - Singapore 552
DE - Germania 498
FI - Finlandia 313
FR - Francia 293
HK - Hong Kong 286
GB - Regno Unito 181
RU - Federazione Russa 163
TR - Turchia 163
IE - Irlanda 158
IN - India 99
SE - Svezia 71
BE - Belgio 53
VN - Vietnam 48
CA - Canada 41
CZ - Repubblica Ceca 32
ID - Indonesia 29
JP - Giappone 22
NL - Olanda 20
AU - Australia 13
IR - Iran 9
BR - Brasile 6
MU - Mauritius 6
PT - Portogallo 5
AR - Argentina 4
CL - Cile 4
EE - Estonia 4
EU - Europa 4
GR - Grecia 4
ES - Italia 3
KR - Corea 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
KG - Kirghizistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
Totale 13.419
Salva come PNG Salva come JPEG
Città #
Fairfield 1.045
Woodbridge 835
Jacksonville 651
Ashburn 565
Warsaw 554
Houston 517
Singapore 471
Cambridge 421
Seattle 420
Ann Arbor 376
Chandler 339
Wilmington 338
Princeton 291
Hong Kong 281
Nanjing 226
Helsinki 202
Brescia 185
Dearborn 169
Dublin 157
Istanbul 147
New York 134
Beijing 129
Nanchang 106
Moscow 85
Shenyang 68
Des Moines 60
Changsha 59
Shanghai 57
Jinan 56
San Diego 55
Brussels 52
Dong Ket 48
Hebei 48
Milan 44
West Jordan 44
Munich 43
Tianjin 43
Pune 42
Boardman 31
Kunming 31
Jiaxing 30
Toronto 30
Jakarta 29
Ningbo 27
Los Angeles 26
London 25
Brno 23
Lancaster 21
Rome 21
Taizhou 21
Verona 21
Zhengzhou 20
Dalmine 18
Hangzhou 17
Haikou 16
Romola 15
Norwalk 14
Ashiya 11
Kocaeli 11
Falkenstein 10
Lanzhou 10
Monmouth Junction 10
Naples 10
San Francisco 10
San Mateo 10
Ardabil 9
Guangzhou 9
Olomouc 9
New Bedfont 8
Turin 8
Washington 8
Augusta 7
Redwood City 7
Espoo 6
Fuzhou 6
Livorno 6
Melbourne 6
Acton 5
Bari 5
Changchun 5
Chicago 5
Dallas 5
Koka 5
Leawood 5
North York 5
Phoenix 5
Sabbio Chiese 5
Salò 5
Santa Clara 5
Vicenza 5
Kilburn 4
Nürnberg 4
Orange 4
São Paulo 4
Vignate 4
Bologna 3
Borås 3
Brooklyn 3
Canberra 3
Catania 3
Totale 10.070
Salva come PNG Salva come JPEG
Nome #
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 239
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 222
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 217
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 191
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 191
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 177
Immunotherapy failure in adrenocortical cancer: where next? 165
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 159
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 157
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 154
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 154
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 151
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 149
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 147
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 146
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 138
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 138
Palbociclib inhibits proliferation of human adrenocortical tumor cells 138
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 138
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 137
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 135
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 132
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 132
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 132
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 131
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 130
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 126
A new pharmacological approach to the facilitation of acetylcholine transmission. 124
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 123
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 118
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 113
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 113
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 111
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 111
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 111
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 111
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 111
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 111
Dopamine receptors are present in rat and human esophagus 110
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 110
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 109
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 109
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 109
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 109
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 109
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 107
Sex-related variations in serum nerve growth factor concentration in humans. 106
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 105
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 105
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 104
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 103
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 102
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 102
Different neurotransmitter systems are involved in the development of esophageal achalasia 101
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 101
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 100
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 100
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 99
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 99
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 99
Nerve growth factor signaling in prostate health and disease. 99
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 97
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 97
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 96
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 96
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 93
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 90
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 90
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 90
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 89
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 87
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 87
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 85
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 85
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 83
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 82
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 81
MUSCARINIC RECEPTOR MESSENGER RNAs ARE DIFFERENTIALLY EXPRESSED IN MALE AND FEMALE NORMAL HUMAN BLADDER 78
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 77
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 77
Phenotype changes of prolactinomas 76
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 76
SUPPRESSION OF TELOMERASE, RE-EXPRESSION OF KAI1 AND ABROGATION OF TUMORIGENICITY BY NGF IN PROSTATE CANCER CELL LINES. 74
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 72
D-1 and D-2 dopamine receptors in rat esophagus: biochemical and functional characterization 71
Identification of Dopamine receptors in rat and human esophagus 71
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 70
Adrenocortical carcinoma 69
Ruolo della dopamina e del VIP sulla funzione motoria del LES nell'acalasia esofagea 66
role of acetylcholine as a growth factor: focus on human urinary bladder 66
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 66
Opposite effects of D2 and D3 dopamine receptors in learning and memory in the rat 66
D-1 and D-2 dopamine receptors are present in human lower esophageal sphincter 65
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 63
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 63
Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. 61
Un'esperienza didattica di promozione della salute per le matricole dei Corsi di Laurea della Facoltà di Medicina e Chirurgia 61
LA STIMOLAZIONE COLINERGICA DETERMINA AUMENTO DELLA PROLIFERAZIONE NELLA LINEA CELLULARE UROTELIALE UROTSA 61
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 61
Epidermal growth factor promotes uncoupling from the adenylate cyclase of the human D2 receptor expressed in GH4C1 cells 60
Totale 10.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.894
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.369 0 0 0 0 0 443 400 406 265 491 137 227
2020/20212.296 74 229 100 285 122 250 107 259 310 219 224 117
2021/20221.260 120 185 38 68 15 58 63 76 61 154 112 310
2022/20231.075 190 62 48 81 83 260 6 90 134 14 39 68
2023/20241.412 72 39 126 101 82 256 49 67 284 73 34 229
2024/20251.243 56 47 32 529 341 238 0 0 0 0 0 0
Totale 13.737